Sequent Scientific informs about resignation of Managing Director

04 Apr 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations’) Sequent Scientific has informed Sharat Pandurang Narasapur, Jt. Managing Director has through his letter dated April 03, 2024 has tendered his resignation from the employment of the Group for personal reasons. Consequently, Sharat Pandurang Narasapur has resigned as a Jt. Managing Director (MD) from the Board of Directors of the Company, with effect from the close of business hours on April 30, 2024. Pursuant to the above, Sharat Pandurang Narasapur shall cease to be a Member of the Corporate Social Responsibility Committee of the Board effective close of business hours on April 30, 2024. However, he shall continue as a Director (Nonexecutive) in the Board of the wholly owned subsidiary Alivira Animal Health. Further, the information required in terms of Regulation 30 read with Schedule III – Para A (7) of Part A of the SEBI Listing Regulations and SEBI Master Circular bearing Ref. No. SEBI/HO/CFD/ PoD2/CIR/P/2023/120 dated July 11, 2023 is enclosed as ‘Annexure-I’ to this letter. The company has attached the letter of resignation received from Sharat Pandurang Narasapur.

The above information is a part of company’s filings submitted to BSE.

Sequent Scientific Share Price

109.75 -0.45 (-0.41%)
24-May-2024 15:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.55
Dr. Reddys Lab 5860.25
Cipla 1482.55
Zydus Lifesciences 1072.35
Lupin 1613.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.